marijuana stocks

Cara Therapeutics to Present at the Virtual BofA Securities 2020 Health Care Conference

A live webcast of the presentation can be accessed under “Events & Presentations” in the News & Investors section of the Company’s website at www.CaraTherapeutics.com. An archived webcast recording will be available on the Cara website for approximately 30 days.

About Cara Therapeutics

Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs. Cara is developing a novel and proprietary class of product candidates, led by KORSUVA™ (CR845/difelikefalin), a first-in-class KOR agonist that targets the body’s peripheral nervous system, as well as certain immune cells. In two Phase 3 trials, KORSUVA Injection has demonstrated statistically significant reductions in itch intensity and concomitant improvement in quality of life measures in hemodialysis patients with moderate-to-severe chronic kidney disease-associated pruritus (CKD-aP). Oral KORSUVA is in Phase 2 trials for the treatment of pruritus in patients with CKD, atopic dermatitis and primary biliary cholangitis.

The FDA has conditionally accepted KORSUVA™ as the trade name for difelikefalin injection. CR845/difelikefalin is an investigational drug product and its safety and efficacy have not been fully evaluated by any regulatory authority.

INVESTOR CONTACT:
Jane Urheim
Stern Investor Relations, Inc.
212-362-1200
jane.urheim@SternIR.com

MEDIA CONTACT:
Annie Starr
6 Degrees
973-415-8838
astarr@6degreespr.com


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Reliq Health Technologies Inc. (RQHTF) Announces Upcoming Shareholder Update Webinar

Reliq Health Technologies, Inc. Announces Upcoming Shareholder Update Webinar Reliq Health Technologies…

4Front Ventures Corp. (FFNTF) Closes on the First Phase of an Up to 558K Sq. Ft. Cultivation and Production Facility

4Front Ventures Corp. Closes on the First Phase of an Up to…

HEXO Corp (HEXO) formalizes US presence by naming Michael Monahan as Chief Financial Officer

HEXO Corp formalizes US presence by naming Michael Monahan as Chief Financial…

$DIRVD Selected for Surveillance Installation at various Colorado Cannabis Facilities

DirectView Security Selected by Evergreen Properties, LLC. for a Comprehensive Security and…